デフォルト表紙
市場調査レポート
商品コード
1386522

スマートピル市場レポート:2030年までの動向、予測、競合分析

Smart Pills Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

スマートピル市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年10月11日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

スマートピルの動向と予測

世界のスマートピル市場は、2024年から2030年までのCAGRが11.6%で、2030年までに推定13億米ドルに達すると予測されます。この市場の主な促進要因は、非侵襲的診断モニタリング装置に対する需要の高まり、結腸がんの罹患率の上昇、カプセル内視鏡の技術進歩の進行です。世界のスマートピル市場は、カプセル内視鏡、標的ドラッグデリバリー、バイタルサインモニタリング市場にビジネスチャンスがあり、将来性が期待されます。

スマートピル市場の洞察

Lucintelは、クローン病、セリアック病、小腸腫瘍などの小腸疾患の顕著な増加により、小腸が予測期間中に最も高い成長を示すと予測しています。

同市場では、消化管疾患の増加や非侵襲的診断法への選好の高まりから、カプセル内視鏡が引き続き最大セグメントとなります。

北米は、炎症性腸疾患の罹患率の増加や同地域における新製品の規制承認により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界のスマートピル市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018年~2023年)と予測(2024年~2030年)
  • 世界のスマートピル市場動向(2018年~2023年)と予測(2024年~2030年)
  • 対象部位別の世界のスマートピル市場
    • 食道
    • 小腸
    • 大腸
  • 用途別の世界のスマートピル市場
    • カプセル内視鏡検査
    • 標的ドラッグデリバリー
    • バイタルサインのモニタリング
  • 最終用途別の世界のスマートピル市場
    • 病院
    • 診断センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のスマートピル市場
  • 北米のスマートピル市場
  • 欧州のスマートピル市場
  • アジア太平洋のスマートピル市場
  • その他地域のスマートピル市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 対象部位別の世界のスマートピル市場の成長機会
    • 用途別の世界のスマートピル市場の成長機会
    • 最終用途別の世界のスマートピル市場の成長機会
    • 地域別の世界のスマートピル市場の成長機会
  • 世界のスマートピル市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のスマートピル市場の生産能力の拡大
    • 世界のスマートピル市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips N.V.
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health
目次

Smart Pills Trends and Forecast

The future of the global smart pills market looks promising with opportunities in the capsule endoscopy, targeted drug delivery, and vital sign monitoring markets. The global smart pills market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 11.6% from 2024 to 2030. The major drivers for this market are growing demand for noninvasive diagnostic monitoring devices, rising incidence of colon cancer, and on-going technological advancements in capsule endoscopy.

A more than 150-page report is developed to help in your business decisions.

Smart Pills by Segment

The study includes a forecast for the global smart pills by target area, application, end use, and region

Smart Pills Market by Target Area [Shipment Analysis by Value from 2018 to 2030]:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Smart Pills Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Capsule Endoscopy
  • Targeted Drug Delivery
  • Vital Sign Monitoring

Smart Pills Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Others

Smart Pills Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Smart Pills Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smart pills companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smart pills companies profiled in this report include-

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips N.V.
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health

Smart Pills Market Insights

Lucintel forecast that small intestine is expected to witness highest growth over the forecast period due to the notable rise in small intestine disorders, such as crohn's disorders, celiac disorders, and small bowel tumors.

Within this market, capsule endoscopy will remain the largest segment due to the increasing number of gastrointestinal disorders and rising prefrence towards non-invasive diagnostic procedures.

North America is expected to witness highest growth over the forecast period due to growing incidence of inflammatory bowel diseases and regulatory approval of new products in the region.

Features of the Global Smart Pills Market

Market Size Estimates: Smart pills market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smart pills market size by target area, application, end use, and region in terms of value ($B).

Regional Analysis: Smart pills market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different target areas, applications, end uses, and regions for the smart pills market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smart pills market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the smart pills market size?

Answer: The global smart pills market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for smart pills market?

Answer: The global smart pills market is expected to grow with a CAGR of 11.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the smart pills market?

Answer: The major drivers for this market are growing demand for noninvasive diagnostic monitoring devices, rising incidence of colon cancer, and on-going technological advancements in capsule endoscopy.

Q4. What are the major segments for smart pills market?

Answer: The future of the smart pills market looks promising with opportunities in the capsule endoscopy, targeted drug delivery, and vital sign monitoring markets.

Q5. Who are the key smart pills market companies?

Answer: Some of the key smart pills companies are as follows:

  • Medtronic
  • HQ
  • IntroMedic
  • OLYMPUS Corporation
  • Koninklijke Philips N.V.
  • Check-Cap
  • JINSHAN Science & Technology
  • CapsoVision
  • RF Co.
  • Proteus Digital Health

Q6. Which smart pills market segment will be the largest in future?

Answer: Lucintel forecast that small intestine is expected to witness highest growth over the forecast period due to the notable rise in small intestine disorders, such as crohn's disorders, celiac disorders, and small bowel tumors.

Q7. In smart pills market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing incidence of inflammatory bowel diseases and regulatory approval of new products in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the smart pills market by target area (esophagus, small intestine, large intestine, and stomach), application (capsule endoscopy, targeted drug delivery, and vital sign monitoring), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smart Pills Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Smart Pills Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Smart Pills Market by Target Area
    • 3.3.1: Esophagus
    • 3.3.2: Small Intestine
    • 3.3.3: Large Intestine
    • 3.3.4: Stomach
  • 3.4: Global Smart Pills Market by Application
    • 3.4.1: Capsule Endoscopy
    • 3.4.2: Targeted Drug Delivery
    • 3.4.3: Vital Sign Monitoring
  • 3.5: Global Smart Pills Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Smart Pills Market by Region
  • 4.2: North American Smart Pills Market
    • 4.2.2: North American Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.3: European Smart Pills Market
    • 4.3.1: European Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.3.2: European Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.4: APAC Smart Pills Market
    • 4.4.1: APAC Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.4.2: APAC Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring
  • 4.5: ROW Smart Pills Market
    • 4.5.1: ROW Smart Pills Market by Target Area: Esophagus, Small Intestine, Large Intestine, and Stomach
    • 4.5.2: ROW Smart Pills Market by Application: Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Smart Pills Market by Target Area
    • 6.1.2: Growth Opportunities for the Global Smart Pills Market by Application
    • 6.1.3: Growth Opportunities for the Global Smart Pills Market by End Use
    • 6.1.4: Growth Opportunities for the Global Smart Pills Market by Region
  • 6.2: Emerging Trends in the Global Smart Pills Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Smart Pills Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smart Pills Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medtronic
  • 7.2: HQ
  • 7.3: IntroMedic
  • 7.4: OLYMPUS Corporation
  • 7.5: Koninklijke Philips N.V.
  • 7.6: Check-Cap
  • 7.7: JINSHAN Science & Technology
  • 7.8: CapsoVision
  • 7.9: RF Co.
  • 7.10: Proteus Digital Health